Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grobe

Showing results (741-750 of 756) with videos related to

Pageof 76
Sort By:
Cerebellum (London, England)|May 22, 2026
A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAXMaresa Buchholz, Victoire Monier, Claire Ewenczyk, et al.
Journal of Neurology|December 12, 2024
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3Tim Lukas Elter, Daniel Sturm, Magda M Santana, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Ebiomedicine|December 24, 2025
Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichmentHannah Baumeister, Philipp Wegner, Mónica Ferreira, et al.
Arquivos Brasileiros De Cardiologia|June 3, 2026
Position Statement on the Management of Antithrombotic and Anticoagulant Therapy in Dengue - 2026Fabio Grunspun Pitta, Matheus de Oliveira Laterza Ribeiro, Antonio Eduardo Pesaro, et al.
Annals of Neurology|November 14, 2023
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Jennifer Faber, Moritz Berger, Carlo Wilke, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Stage-dependent biomarker changes in spinocerebellar ataxia type 3Jennifer Faber, Moritz Berger, Wilke Carlo, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortMoritz Berger, Hector Garcia-Moreno, Monica Ferreira, et al.
BMC Cancer|December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Revista De Gastroenterologia De Mexico (English)|February 4, 2019
The Mexican consensus on nonalcoholic fatty liver diseaseR Bernal-Reyes, G Castro-Narro, R Malé-Velázquez, et al.
Pageof 76

Showing results (741-750 of 756) with videos related to

Sort By:
Pageof 76
Cerebellum (London, England)|May 22, 2026
A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAXMaresa Buchholz, Victoire Monier, Claire Ewenczyk, et al.
Journal of Neurology|December 12, 2024
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3Tim Lukas Elter, Daniel Sturm, Magda M Santana, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Ebiomedicine|December 24, 2025
Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichmentHannah Baumeister, Philipp Wegner, Mónica Ferreira, et al.
Arquivos Brasileiros De Cardiologia|June 3, 2026
Position Statement on the Management of Antithrombotic and Anticoagulant Therapy in Dengue - 2026Fabio Grunspun Pitta, Matheus de Oliveira Laterza Ribeiro, Antonio Eduardo Pesaro, et al.
Annals of Neurology|November 14, 2023
Stage-Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Jennifer Faber, Moritz Berger, Carlo Wilke, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Stage-dependent biomarker changes in spinocerebellar ataxia type 3Jennifer Faber, Moritz Berger, Wilke Carlo, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortMoritz Berger, Hector Garcia-Moreno, Monica Ferreira, et al.
BMC Cancer|December 7, 2016
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011Olaf Schoffer, Stefanie Schülein, Gerlinde Arand, et al.
Revista De Gastroenterologia De Mexico (English)|February 4, 2019
The Mexican consensus on nonalcoholic fatty liver diseaseR Bernal-Reyes, G Castro-Narro, R Malé-Velázquez, et al.
Pageof 76